181 related articles for article (PubMed ID: 31295057)
1. Adoption of the 275-patient buprenorphine treatment waiver for treating opioid use disorder: A state-level longitudinal analysis.
Knudsen HK; Lin LA; Lofwall MR
Subst Abus; 2020; 41(2):259-268. PubMed ID: 31295057
[No Abstract] [Full Text] [Related]
2. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.
Stein BD; Pacula RL; Gordon AJ; Burns RM; Leslie DL; Sorbero MJ; Bauhoff S; Mandell TW; Dick AW
Milbank Q; 2015 Sep; 93(3):561-83. PubMed ID: 26350930
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
Jones CM; McCance-Katz EF
Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
[TBL] [Abstract][Full Text] [Related]
4. Prescribing Practices of Rural Physicians Waivered to Prescribe Buprenorphine.
Andrilla CHA; Coulthard C; Patterson DG
Am J Prev Med; 2018 Jun; 54(6 Suppl 3):S208-S214. PubMed ID: 29779544
[TBL] [Abstract][Full Text] [Related]
5. The Supply of Physicians Waivered to Prescribe Buprenorphine for Opioid Use Disorders in the United States: A State-Level Analysis.
Knudsen HK
J Stud Alcohol Drugs; 2015 Jul; 76(4):644-54. PubMed ID: 26098042
[TBL] [Abstract][Full Text] [Related]
6. Changes in Waivered Clinicians Prescribing Buprenorphine and Prescription Volume by Patient Limit.
Luo Q; Erikson CE
JAMA; 2023 May; 329(20):1792-1794. PubMed ID: 37103912
[TBL] [Abstract][Full Text] [Related]
7. Buprenorphine waiver uptake among nurse practitioners and physician assistants: The role of existing waivered prescriber supply.
Auty SG; Stein MD; Walley AY; Drainoni ML
J Subst Abuse Treat; 2020 Aug; 115():108032. PubMed ID: 32600629
[TBL] [Abstract][Full Text] [Related]
8. Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees.
Wen H; Hockenberry JM; Pollack HA
JAMA Netw Open; 2018 Sep; 1(5):e182943. PubMed ID: 30646185
[TBL] [Abstract][Full Text] [Related]
9. Prescribing patterns of buprenorphine waivered physicians.
Thomas CP; Doyle E; Kreiner PW; Jones CM; Dubenitz J; Horan A; Stein BD
Drug Alcohol Depend; 2017 Dec; 181():213-218. PubMed ID: 29096292
[TBL] [Abstract][Full Text] [Related]
10. Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder.
Andrilla CHA; Coulthard C; Larson EH
Ann Fam Med; 2017 Jul; 15(4):359-362. PubMed ID: 28694273
[TBL] [Abstract][Full Text] [Related]
11. Geographic and specialty distribution of US physicians trained to treat opioid use disorder.
Rosenblatt RA; Andrilla CH; Catlin M; Larson EH
Ann Fam Med; 2015; 13(1):23-6. PubMed ID: 25583888
[TBL] [Abstract][Full Text] [Related]
12. Growth and Distribution of Buprenorphine-Waivered Providers in the United States, 2007-2017.
McBain RK; Dick A; Sorbero M; Stein BD
Ann Intern Med; 2020 Apr; 172(7):504-506. PubMed ID: 31905379
[No Abstract] [Full Text] [Related]
13. Physicians' satisfaction with providing buprenorphine treatment.
Knudsen HK; Brown R; Jacobson N; Horst J; Kim JS; Collier E; Starr S; Madden LM; Haram E; Toy A; Molfenter T
Addict Sci Clin Pract; 2019 Aug; 14(1):34. PubMed ID: 31446893
[TBL] [Abstract][Full Text] [Related]
14. Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002-11.
Dick AW; Pacula RL; Gordon AJ; Sorbero M; Burns RM; Leslie D; Stein BD
Health Aff (Millwood); 2015 Jun; 34(6):1028-34. PubMed ID: 26056209
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, Distribution, and Characteristics Associated With Possession of Buprenorphine Waivers Among Infectious Diseases Physicians in the United States.
Fujita AW; Loughry N; Moore DE; Carter AE; Hussen SA; Cooper H; Colasanti JA; Sheth AN
Clin Infect Dis; 2023 Apr; 76(7):1197-1204. PubMed ID: 36419250
[TBL] [Abstract][Full Text] [Related]
16. U.S. trends in the supply of providers with a waiver to prescribe buprenorphine for opioid use disorder in 2016 and 2018.
Ghertner R
Drug Alcohol Depend; 2019 Nov; 204():107527. PubMed ID: 31525570
[TBL] [Abstract][Full Text] [Related]
17. Buprenorphine dispensing before and after the April 2021 X-Waiver exemptions: An interrupted time series analysis.
Roy PJ; Suda K; Luo J; Lee M; Anderton J; Olejniczak D; Liebschutz JM
Int J Drug Policy; 2024 Apr; 126():104381. PubMed ID: 38457960
[TBL] [Abstract][Full Text] [Related]
18. Association of a Multimodal Educational Intervention for Primary Care Physicians With Prescriptions of Buprenorphine for Opioid Use Disorders.
Clark B; Kai M; Dix R; White J; Rozenfeld Y; Levy S; Engstrom K
JAMA Netw Open; 2019 Oct; 2(10):e1913818. PubMed ID: 31642929
[TBL] [Abstract][Full Text] [Related]
19. Interest in prescribing buprenorphine among resident and attending physicians at an urban teaching clinic.
James JR; Gordon LM; Klein JW; Merrill JO; Tsui JI
Subst Abus; 2019; 40(1):11-13. PubMed ID: 29578857
[No Abstract] [Full Text] [Related]
20. Trends In Buprenorphine Prescribing By Physician Specialty.
Wen H; Borders TF; Cummings JR
Health Aff (Millwood); 2019 Jan; 38(1):24-28. PubMed ID: 30615523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
